Patent · US Expired

ACAT inhibitory benzanilides

US5159114A · kind A · utility

3Cited by
2References
10Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 5, 1991
Grant dateOct 27, 1992
Priority date
Expiry dateAug 5, 2011

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D307/52
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Benzanilide derivatives of the formula: ##STR1## wherein R.sup.1 is alkyl optionally containing double or triple bonds, and optionally interrupted by one or more hetero atoms; R.sup.2 is hydrogen, methyl, or ethyl; PA0 R.sup.3 is halogen, alkyl, --OY, --SY, or dimethylamino; R.sup.4 and R.sup.5 are hydrogen, alkyl optionally containing double or triple bonds, or --(CH.sub.2).sub.m --Z, wherein: Z is --OCH.sub.3, --SCH.sub.3, --N(CH.sub.3).sub.2 or alkanoylamino, and m is 2, 3 or 4; PA0 X is oxygen, --OCH.sub.2 --, --S--, --SCH.sub.2 -- or --NR.sup.6 --; PA0 R.sup.6 is hydrogen, methyl, ethyl, or acyl; and PA0 Y is alkyl; are useful as anti-atherosclerotic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.